Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$1.53 +9.7%	$1.78	$0.90 ▼ $4.98	$382.65M	2.45	3.69 million shs	4.32 million shs
DCTH Delcath Systems	$11.12 +6.8%	$11.87	$7.85 ▼ $18.23	$388.99M	0.82	843,954 shs	771,937 shs
ICAD icad	$3.87	$3.82	$1.19 ▼ $4.02	$106.31M	1.37	426,282 shs	N/A
RXST RxSight	$9.28 +6.3%	$9.72	$6.32 ▼ $58.23	$379.70M	1.16	1.16 million shs	1.35 million shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	0.00%	+6.64%	-26.86%	-30.05%	+63.28%
DCTH Delcath Systems	0.00%	+7.34%	-2.46%	-30.97%	+39.52%
ICAD icad	0.00%	0.00%	0.00%	+3.75%	+127.65%
RXST RxSight	0.00%	+10.08%	+16.88%	-40.82%	-82.71%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BFLY Butterfly Network	2.9501 of 5 stars	3.4	3.0	0.0	0.0	2.6	2.5	0.6
DCTH Delcath Systems	2.7805 of 5 stars	3.5	2.0	0.0	0.0	2.6	2.5	0.6
ICAD icad	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RXST RxSight	0.9734 of 5 stars	2.0	1.0	0.0	0.0	2.3	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFLY Butterfly Network	2.75	Moderate Buy	$3.00	96.72% Upside
DCTH Delcath Systems	3.00	Buy	$24.50	120.32% Upside
ICAD icad	2.00	Hold	N/A	N/A
RXST RxSight	1.91	Reduce	$10.00	7.76% Upside

Current Analyst Ratings Breakdown

Latest ICAD, DCTH, BFLY, and RXST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	RXST RxSight	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$16.00 ➝ $8.00
8/8/2025	RXST RxSight	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$9.00 ➝ $8.00
8/8/2025	RXST RxSight	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$22.00 ➝ $11.00
8/7/2025	DCTH Delcath Systems	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$29.00 ➝ $31.00
8/4/2025	BFLY Butterfly Network	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Positive ➝ Positive	$2.00
8/1/2025	BFLY Butterfly Network	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform
7/15/2025	RXST RxSight	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$20.00 ➝ $9.00
7/10/2025	RXST RxSight	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$24.00 ➝ $9.00
7/9/2025	RXST RxSight	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underperform ➝ Underperform	$18.00 ➝ $9.00
7/9/2025	RXST RxSight	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$18.00 ➝ $10.00
7/9/2025	RXST RxSight	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$17.00 ➝ $9.00

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFLY Butterfly Network	$82.06M	4.68	N/A	N/A	$0.79 per share	1.93
DCTH Delcath Systems	$37.21M	10.45	N/A	N/A	$2.15 per share	5.17
ICAD icad	$19.61M	5.42	N/A	N/A	$1.08 per share	3.58
RXST RxSight	$139.93M	2.71	N/A	N/A	$6.98 per share	1.33

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFLY Butterfly Network	-$72.49M	-$0.28	N/A	N/A	N/A	-71.79%	-30.53%	-21.80%	11/7/2025 (Estimated)
DCTH Delcath Systems	-$26.39M	$0.05	222.40	N/A	N/A	3.18%	6.91%	5.80%	N/A
ICAD icad	-$5.62M	-$0.19	N/A	∞	N/A	-26.63%	-15.03%	-11.77%	N/A
RXST RxSight	-$27.45M	-$0.80	N/A	N/A	N/A	-21.93%	-11.56%	-10.31%	11/6/2025 (Estimated)

Latest ICAD, DCTH, BFLY, and RXST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Guidance Update	RXST RxSight	-$0.04	-$0.08	-$0.04	-$0.29	$39.78 million	$33.64 million
8/6/2025	Q2 2025	DCTH Delcath Systems	$0.02	$0.07	+$0.05	$0.07	$22.84 million	$24.16 million
8/1/2025	Q2 2025	BFLY Butterfly Network	-$0.07	-$0.06	+$0.01	-$0.06	$23.91 million	$23.38 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
DCTH Delcath Systems	N/A	N/A	N/A	N/A	N/A
ICAD icad	N/A	N/A	N/A	N/A	N/A
RXST RxSight	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFLY Butterfly Network	N/A	5.68	4.14
DCTH Delcath Systems	N/A	10.88	9.87
ICAD icad	N/A	3.66	3.57
RXST RxSight	N/A	13.93	12.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFLY Butterfly Network	37.85%
DCTH Delcath Systems	61.12%
ICAD icad	24.61%
RXST RxSight	78.78%

Insider Ownership

Company	Insider Ownership
BFLY Butterfly Network	25.18%
DCTH Delcath Systems	17.94%
ICAD icad	10.29%
RXST RxSight	9.57%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFLY Butterfly Network	460	251.74 million	188.35 million	Optionable
DCTH Delcath Systems	60	34.98 million	28.71 million	Optionable
ICAD icad	140	27.47 million	24.64 million	Optionable
RXST RxSight	220	40.92 million	37.00 million	Optionable

ICAD, DCTH, BFLY, and RXST Headlines

Recent News About These Companies

ROSEN, NATIONAL TRIAL COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RXST

August 24 at 9:10 AM | markets.businessinsider.com

RxSight, Inc. $RXST Shares Bought by Quantbot Technologies LP

August 24 at 5:16 AM | marketbeat.com

RXST CLASS REMINDER: Suffer Losses on Your RxSight, Inc. Investment? Contact BFA Law before the September 22 Court Deadline (NASDAQ:RXST)

August 23 at 7:08 AM | globenewswire.com

ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST

August 22 at 5:56 PM | globenewswire.com

Lost Money on RxSight, Inc.(RXST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

August 22 at 4:43 PM | globenewswire.com

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

August 22 at 10:25 AM | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST

August 22 at 10:00 AM | prnewswire.com

RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST

August 22 at 8:45 AM | prnewswire.com

Credit Agricole S A Has $19.85 Million Position in RxSight, Inc. $RXST

August 22 at 5:48 AM | marketbeat.com

Algert Global LLC Has $3.51 Million Stock Position in RxSight, Inc. $RXST

August 22 at 4:44 AM | marketbeat.com

RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit

August 21 at 9:26 PM | prnewswire.com

Lost Money on RxSight, Inc.(RXST)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm

August 21 at 3:23 PM | globenewswire.com

Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

August 21 at 1:58 PM | globenewswire.com

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

August 21 at 11:25 AM | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST

August 21 at 10:36 AM | globenewswire.com

Class Action Filed Against RxSight, Inc. (RXST) - September 22, 2025 Deadline to Join - Contact The Gross Law Firm

August 21 at 8:45 AM | prnewswire.com

RXST DEADLINE NOTICE: RxSight, Inc. Investors are Notified of the September 22 Class Action Deadline -- Contact BFA Law if You Suffered Losses (NASDAQ:RXST)

August 21 at 8:18 AM | globenewswire.com

Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd

August 21 at 7:05 AM | prnewswire.com

RXST Stockholders with Large Losses Should Contact Robbins LLP for Information About the RxSight, Inc. Class Action

August 20, 2025 | prnewswire.com

RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

August 20, 2025 | globenewswire.com

RXST SECURITIES: RxSight, Inc. Shareholders that Lost Money may have been Affected by Fraud -- ...

August 19, 2025 | gurufocus.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICAD, DCTH, BFLY, and RXST Company Descriptions

Butterfly Network NYSE:BFLY

$1.52 +0.14 (+9.71%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$1.52 0.00 (0.00%)

As of 08/22/2025 07:57 PM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Delcath Systems NASDAQ:DCTH

$11.12 +0.71 (+6.82%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$11.06 -0.06 (-0.55%)

As of 08/22/2025 07:42 PM Eastern

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

icad NASDAQ:ICAD

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

RxSight NASDAQ:RXST

$9.28 +0.55 (+6.30%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$9.24 -0.04 (-0.43%)

As of 08/22/2025 07:46 PM Eastern

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time